These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22685455)

  • 21. Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study.
    Megna M; Fornaro L; Potestio L; Luciano MA; Nocerino M; Delfino M; Guarino M; Fabbrocini G; Camela E
    Psoriasis (Auckl); 2022; 12():199-204. PubMed ID: 35844291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Managing moderate-to-severe psoriasis in the elderly.
    Balato N; Patruno C; Napolitano M; Patrì A; Ayala F; Scarpa R
    Drugs Aging; 2014 Apr; 31(4):233-8. PubMed ID: 24554398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Unmet Need for Clinical Guidelines on the Management of Patients with Plaque Psoriasis in Africa and the Middle East.
    Steinhoff M; Ammoury AF; Ahmed HM; Gamal MFS; El Sayed MH
    Psoriasis (Auckl); 2020; 10():23-28. PubMed ID: 32944566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel.
    Papp KA; Beecker J; Cooper C; Kirchhof MG; Pozniak AL; Rockstroh JK; Dutz JP; Gooderham MJ; Gniadecki R; Hong CH; Lynde CW; Maari C; Poulin Y; Vender RB; Walmsley SL
    Dermatol Ther (Heidelb); 2022 May; 12(5):1073-1089. PubMed ID: 35445963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments.
    Gisondi P; Bellinato F; Chiricozzi A; Girolomoni G
    Vaccines (Basel); 2020 Dec; 8(4):. PubMed ID: 33276686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey.
    Lebwohl M; Langley RG; Paul C; Puíg L; Reich K; van de Kerkhof P; Wu HL; Richter S; Jardon S; Gisondi P
    Dermatol Ther (Heidelb); 2022 Jan; 12(1):61-78. PubMed ID: 34704231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing Mild-to-Moderate Psoriasis in Elderly Patients: Role of Topical Treatments.
    Kamel JG; Yamauchi PS
    Drugs Aging; 2017 Aug; 34(8):583-588. PubMed ID: 28755089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.
    Bronckers IMGJ; Seyger MMB; West DP; Lara-Corrales I; Tollefson M; Tom WL; Hogeling M; Belazarian L; Zachariae C; Mahé E; Siegfried E; Philipp S; Szalai Z; Vleugels RA; Holland K; Murphy R; Baselga E; Cordoro K; Lambert J; Alexopoulos A; Mrowietz U; Kievit W; Paller AS;
    JAMA Dermatol; 2017 Nov; 153(11):1147-1157. PubMed ID: 28903160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.
    Papp KA; Melosky B; Sehdev S; Hotte SJ; Beecker JR; Kirchhof MG; Turchin I; Dutz JP; Gooderham MJ; Gniadecki R; Hong CH; Lambert J; Lynde CW; Prajapati VH; Vender RB
    Dermatol Ther (Heidelb); 2023 Apr; 13(4):867-889. PubMed ID: 36929121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease and Treatment Characteristics in Geriatric Psoriasis: A Patient Survey Comparing Age Groups.
    van Winden MEC; ter Haar ELM; Groenewoud HMM; van de Kerkhof PCM; de Jong EMGJ; Lubeek SFK
    Acta Derm Venereol; 2020 Jul; 100(14):adv00215. PubMed ID: 32556353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis.
    Huang W; Cordoro KM; Taylor SL; Feldman SR
    J Am Acad Dermatol; 2008 Jun; 58(6):970-7. PubMed ID: 18384909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psoriasis in the mature patient: Therapeutic approach in the era of biologics.
    Kostović K; Žužul K; Čeović R; Bukvić Mokos Z
    Clin Dermatol; 2018; 36(2):222-230. PubMed ID: 29566926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing the Treatment of Moderate-to-Severe Psoriasis in Older Adults.
    Shary N; Kalb RE
    Drugs Aging; 2020 Oct; 37(10):715-723. PubMed ID: 32776216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis.
    Maruani A; Samimi M; Stembridge N; Abdel Hay R; Tavernier E; Hughes C; Le Cleach L
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011541. PubMed ID: 30958563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologics in pediatric psoriasis - efficacy and safety.
    Dogra S; Mahajan R
    Expert Opin Drug Saf; 2018 Jan; 17(1):9-16. PubMed ID: 29022425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of psoriasis as a systemic disease: what is the evidence?
    Korman NJ
    Br J Dermatol; 2020 Apr; 182(4):840-848. PubMed ID: 31225638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of current systemic therapies for nail psoriasis.
    Hwang JK; Lipner SR
    Expert Opin Drug Saf; 2023; 22(5):391-406. PubMed ID: 37329288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials.
    Schmitt J; Rosumeck S; Thomaschewski G; Sporbeck B; Haufe E; Nast A
    Br J Dermatol; 2014 Feb; 170(2):274-303. PubMed ID: 24131260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.